Precision Oncology for Stage IV Solid Tumors
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Recruiting
N/A
Interventional Study
Solid Tumor Malignancies
Metastatic Cancer
Breast Cancer
Colorectal Cancer
Lung Cancer
Bladder Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 500 (estimated)
- Sponsor
- UNC Lineberger Comprehensive Cancer Center · Other
Who this trial is looking for
This trial is looking for adults with stage IV solid tumors like breast, lung, colorectal, or bladder cancer. Participants will receive support in understanding their genetic test results for better treatment options.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old.
- I have been diagnosed with stage IV solid tumor malignancy.
- I have given written consent to participate.
- My doctor thinks genetic testing is appropriate for my treatment.
- I have not had a genomic tumor test ordered, or the test was ordered but the results are not available.
- I am able to follow study procedures as determined by my doctor.
- I have an ECOG or Karnofsky Performance Status of 0-2.
You may not be able to join if
- I have an active cancer in addition to my solid tumor malignancy.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a hybrid decentralized, single-arm, interventional study designed to evaluate the impact of precision medicine navigation and reflexive expert review of next-generation sequencing (NGS) for patients with stage IV solid tumor malignancies (breast, lung, colorectal, and bladder cancers).
The purpose of this study is to investigate whether intervention from a centralized precision oncology n…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
In order to participate in this study a subject must meet all of the eligibility criteria outlined below.
Inclusion Criteria
* Written informed consent was obtained to participate in the study and HIPAA authorization for release of personal health information.
* Subjects are willing and able to co…
Contacts